Drug profile · INN
metoclopramide
APO-METOCLOPRAMIDE
metoclopramide (APO-METOCLOPRAMIDE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — metoclopramide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
metoclopramide (APO-METOCLOPRAMIDE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN metoclopramide
Brand APO-METOCLOPRAMIDE
Mechanism Dopamine D2 receptor antagonist
Originator Alphapharm Pty Ltd
Mechanism of action
Dopamine D2 receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is metoclopramide?
metoclopramide (APO-METOCLOPRAMIDE) is a dopamine d2 receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for metoclopramide?
APO-METOCLOPRAMIDE is a marketed brand name for metoclopramide. Check FDA Drugs@FDA for the current US label holder and prescribing information.